Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Gateway Analytical, an Aptar Pharma companyGateway Analytical, an Aptar Pharma company
VS
Ipca Laboratories LimitedIpca Laboratories Limited
Gateway Analytical, an Aptar Pharma company

Gateway Analytical, an Aptar Pharma company

2009 Kramer Rd., Gibsonia, PA, 15044, US

Last Update: 22/05/2026

View Profile
752/1000Fair

Gateway Analytical is the innovative analytical testing laboratory that businesses around the world trust to provide solutions for their most challenging foreign particulate analysis, foreign particulate identification and materials analysis needs. Gateway’s expert ...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:40
Subsidiaries:9
12-month incidents
0
Known data breaches
0
Attack type number
0
Ipca Laboratories Limited

Ipca Laboratories Limited

125 Kandivli Industrial Estate, Kandivli (West), Mumbai, Maharashtra, IN, 400067

Last Update: 02/04/2026

View Profile
Between 750 and 799
https://www.ipca.com/
768/1000Fair

A consumer-led global pharmaceutical company, creating healthy doses of life since 1949. When you operate in an industry like pharmaceuticals, your work goes way beyond creating ‘products for customers’. It is different from any other domain – there lies a higher sense...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:13,559
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Gateway Analytical, an Aptar Pharma company

Gateway Analytical, an Aptar Pharma company

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Ipca Laboratories Limited

Ipca Laboratories Limited

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Gateway Analytical, an Aptar Pharma company in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Ipca Laboratories Limited in 2026.

Incidents

Incident History - Gateway Analytical, an Aptar Pharma company (X = Date, Y = Severity)

Gateway Analytical, an Aptar Pharma company cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Ipca Laboratories Limited (X = Date, Y = Severity)

Ipca Laboratories Limited cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Gateway Analytical, an Aptar Pharma company

Gateway Analytical, an Aptar Pharma company

Incidents
No explicit notable incidents reported.
Ipca Laboratories Limited

Ipca Laboratories Limited

Incidents
No explicit notable incidents reported.

FAQ

Between Gateway Analytical, an Aptar Pharma company company and Ipca Laboratories Limited company, which one has the best AI Cybersecurity Score ?
Between Gateway Analytical, an Aptar Pharma company company and Ipca Laboratories Limited company, which one has experienced more cyber incidents in the past ?
Between Gateway Analytical, an Aptar Pharma company company and Ipca Laboratories Limited company, which one has experienced more cyber incidents this year ?
Between Gateway Analytical, an Aptar Pharma company company and Ipca Laboratories Limited company, which one has experienced at least one ransomware attack ?
Between Gateway Analytical, an Aptar Pharma company company and Ipca Laboratories Limited company, which one has experienced at least one data breach ?
Between Gateway Analytical, an Aptar Pharma company company and Ipca Laboratories Limited company, which one has experienced at least one targeted cyberattack ?
Between Gateway Analytical, an Aptar Pharma company company and Ipca Laboratories Limited company, which one has experienced at least one vulnerability ?
Between Gateway Analytical, an Aptar Pharma company company and Ipca Laboratories Limited company, which one holds the most compliance certifications ?
Between Gateway Analytical, an Aptar Pharma company company and Ipca Laboratories Limited company, which one holds the fewest compliance certifications ?
Between Gateway Analytical, an Aptar Pharma company company and Ipca Laboratories Limited company, which one has the most subsidiaries ?
Between Gateway Analytical, an Aptar Pharma company company and Ipca Laboratories Limited company, which one has the largest number of employees ?
Between Gateway Analytical, an Aptar Pharma company and Ipca Laboratories Limited, which company holds both SOC 2 Type 1 certifications ?
Between Gateway Analytical, an Aptar Pharma company and Ipca Laboratories Limited, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Gateway Analytical, an Aptar Pharma company or Ipca Laboratories Limited ?
Which company is PCI DSS compliant - Gateway Analytical, an Aptar Pharma company or Ipca Laboratories Limited ?
Between Gateway Analytical, an Aptar Pharma company and Ipca Laboratories Limited, which company complies with HIPAA regulations for healthcare data ?
Between Gateway Analytical, an Aptar Pharma company and Ipca Laboratories Limited, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-86544
SUMMARY

knowns versions before 0.30.0 contain an authorization bypass vulnerability where mutating code actions are incorrectly classified as read-only operations. Attackers with read-restricted sessions can exploit code.replace to modify permission configurations and escalate privileges on subsequent calls.

PUBLISHED
Date2026-09-07
UPDATED
Date2026-09-07
RISK INFORMATION (Score: 8.1)
CVSS3
Base Score: 8.1
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:H/A:H
CVSS4
Base Score: 7.2
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:N/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.2
EXPLOITABILITY
2.8
CVE-2026-86543
SUMMARY

knowns versions before 0.30.0 serve the management API without authentication on all network interfaces by default, with no password required on fresh installations. Attackers can access the unauthenticated /api/tunnel/start endpoint to provision a public tunnel and republish the API at a publicly accessible address.

PUBLISHED
Date2026-09-07
UPDATED
Date2026-09-07
RISK INFORMATION (Score: 9.8)
CVSS3
Base Score: 9.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
CVSS4
Base Score: 9.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.9
EXPLOITABILITY
3.9
CVE-2026-86542
SUMMARY

knowns before 0.30.0 fails to validate import names in the import routes, allowing unauthenticated attackers to write files outside the imports directory. Attackers can supply traversal sequences in the name parameter to escape the imports directory and overwrite arbitrary files writable by the server process.

PUBLISHED
Date2026-09-07
UPDATED
Date2026-09-07
RISK INFORMATION (Score: 9.1)
CVSS3
Base Score: 9.1
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:H/A:H
CVSS4
Base Score: 8.8
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.2
EXPLOITABILITY
3.9
CVE-2026-86541
SUMMARY

knowns versions before 0.30.0 contain a path traversal vulnerability in the handleCodeReplace() function that allows attackers to overwrite arbitrary files outside the project root. Attackers can supply absolute paths or relative paths containing directory traversal sequences to write malicious content to sensitive files like shell startup scripts or SSH configuration files.

PUBLISHED
Date2026-09-07
UPDATED
Date2026-09-07
RISK INFORMATION (Score: 8.3)
CVSS3
Base Score: 8.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:H/A:H
CVSS4
Base Score: 7.2
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:L/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.5
EXPLOITABILITY
2.8
CVE-2026-86540
SUMMARY

knowns versions before 0.30.0 fail to validate the settings.lsp.languages binary field in project configuration files, allowing attackers to execute arbitrary binaries by crafting a malicious .knowns/config.json file. When a repository with a crafted configuration is opened, the unvalidated binary path is executed twice under the user's account without any verification.

PUBLISHED
Date2026-09-07
UPDATED
Date2026-09-07
RISK INFORMATION (Score: 7.8)
CVSS3
Base Score: 7.8
Complexity: LOW
CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H
CVSS4
Base Score: 8.5
Complexity: LOW
CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:P/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.9
EXPLOITABILITY
1.8